- Filed
- Jan 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jan 12, 2026 | 14.38M sh |
| Shares Diluted | Q1 2026 · Nov 30, 2025 | 14.38M sh |
| Shares Diluted | Q1 2026 · Nov 30, 2024 | 14.38M sh |
| Operating Cash Flow | Q1 2026 · Nov 30, 2025 | −$1.48K |
| Operating Cash Flow | Q1 2026 · Nov 30, 2024 | −$975 |
| Cash And Equivalents | Q1 2026 · Nov 30, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Aug 31, 2025 | $1.48K |
| Stockholders Equity | Q1 2026 · Nov 30, 2025 | −$52.16K |
| Stockholders Equity | Q1 2026 · Aug 31, 2025 | −$42.08K |
| Stockholders Equity | Q1 2026 · Nov 30, 2024 | −$13.15K |
| Stockholders Equity | Q1 2026 · Aug 31, 2024 | −$79.16K |
| Current Liabilities | Q1 2026 · Nov 30, 2025 | $58.93K |
| Current Liabilities | Q1 2026 · Aug 31, 2025 | $52.32K |
| Current Assets | Q1 2026 · Nov 30, 2025 | $6.77K |
| Current Assets | Q1 2026 · Aug 31, 2025 | $10.25K |
| Total Assets | Q1 2026 · Nov 30, 2025 | $6.77K |
| Total Assets | Q1 2026 · Aug 31, 2025 | $10.25K |
| Eps Diluted | Q1 2026 · Nov 30, 2025 | $0.00 |
| Eps Diluted | Q1 2026 · Nov 30, 2024 | $0.00 |
| Sga Expense | Q1 2026 · Nov 30, 2025 | $32 |
| Sga Expense | Q1 2026 · Nov 30, 2024 | $226 |
| Net Income | Q1 2026 · Nov 30, 2025 | −$10.08K |
| Net Income | Q1 2026 · Nov 30, 2024 | −$7.82K |
| Operating Income | Q1 2026 · Nov 30, 2025 | −$10.08K |
| Operating Income | Q1 2026 · Nov 30, 2024 | −$7.82K |
| Gross Profit | Q1 2026 · Nov 30, 2025 | $200 |
| Gross Profit | Q1 2026 · Nov 30, 2024 | $0 |
| Cost Of Revenue | Q1 2026 · Nov 30, 2025 | $2K |
| Cost Of Revenue | Q1 2026 · Nov 30, 2024 | $0 |
| Revenue | Q1 2026 · Nov 30, 2025 | $2.2K |
| Revenue | Q1 2026 · Nov 30, 2024 | $0 |